학술논문

Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
Document Type
Article
Source
In The Lancet Respiratory Medicine May 2019 7(5):437-446
Subject
Primary Research
Articles
Language
ISSN
2213-2600